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On the caver: 
In every discipline, f r o m 
gynecology to endocrinol-
ogy, medical technology is 
helping physicians to 
conquer a broad spectrum 
of l i fe-altering and l ife-
threatening diseases. Using 
a computerized image of a 
woman's spine, wr is t or hip 
(as shown), physicians at 
the Hospital 's new Evans 
Bone Health, Diabetes and 
C l i n i c a l Endocrinology 
Group are able to diagnose, 
prevent and treat diseases 
of the bone, i n c l u d i n g 
osteoporosis, a condi t ion 
that most often afflicts 
w o m e n . 
Model is f u d i t h A. Paige. 
Photography by Lou Jones 
(copyrigbt© 1993). 
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You Can Feel it in Your Bones 
Is osteoporosis inevitable? Pbysicians 
at the Hospital's new Evans Bone 
Health, Diabetes and Cl in ica l 
Endocrinology Group are focusing 
their efforts on prevention and early 
detection of this debi l i tat ing condi-
t i o n i n tbe bopes that w o m e n (and 
men) can mainta in healthy bones. 
PAGE n 
Giving Women a Psychological Edge 
Hospital 
surgeons 
affi l iated w i t h 
B U M C H ' s 
Breast Heal th 
Center are 
giving 
mastectomy 
patients a 
psychological 
edge by offering 
them the opt ion of post-mastectomy 
breast reconstruction. 
PAGE t-
A Wider Scope of Expertise 
Hospital gynecologists are f inding 
new opportunities for tbe use of 
minimal-access surgery tecbniques i n 
the detection and treatment of a wide 
range of common yet distressing 
gynecologic disorders. 
PAGE 8 
Women and Aging 
If you're a w o m a n then your chances 
of growing old alone and i n fa i l ing 
health are fair ly high. The Hospital 's 
new chief of geriatric medicine, 
Patricia P. Barry, M . D . , provides 
insight in to a variety of topics 
affecting w o m e n and aging, inc luding 
how w o m e n might age successfully. 
PAGE 10 
Detecting Bulimia 
By asking t w o simple questions, 
physicians at the Hospital 's Women's 
Heal th Group are better able to detect 
the hidden problem of b u l i m i a . 
PAGE 
Stem Cells to the Rescue 
Cancer and blood experts bere are 
testing the efficacy of a new alterna-
tive to hone-marrow transplanta-
t i o n — w i t h favorable results. 
PAGE 12 
Following up on Progress 
Progress magazine fol lows up on the 
early promise of t w o cl inical ap-
proaches. 
PAGE 14 
News & Names 
Hospital opens the doors to a new 
primary care satellite.. .new trustee 
chairman, overseers named.. .Medical 
Center hosts Senate hearing on 
women's health issues...MRI technol-
ogy upgraded...staff appointments. 
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You C A N FEEL IT IN YOUR BONES 
Early detection and prevention of osteoporosis are key components 
of a new multidisciplinary program 
BY ERICA SAPERSTEIN 
focus on women's 
health concerns 
steoporosis, or the degen-
erat ion of bone, affl icts 
and debilitates some 20 
m i l l i o n people each year, 
. and is the number-one 
cause of h i p fractures. However , 
thanks to insights i n t o the physio l -
ogy of the disease and advances i n 
developing therapies to treat i t , the 
disorder can usual ly he prevented if 
behavioral measures are begun early 
i n l i fe , or stalled or treated i f diag-
nosed early. 
Members of the Hospital 's n e w 
Evans Bone H e a l t h , Diabetes and 
C l i n i c a l Endocrinology Group are 
experts i n the f i e ld of 
osteoporosis prevent ion, 
detect ion and treatment , 
and have developed an 
aggressive, 
m u l t i d i s c i p l i n a r y 
approach to prevent ion 
and early detect ion of the 
disease. F r o m stressing 
proper diet and l i festyle 
behaviors i n adolescents 
w h o have a f a m i l y 
h is tory of the disease, to 
prescribing therapeutic G /cDk 
measures to people 
s h o w i n g early signs of 
onset, the ir goal is to 
lessen the burden of th is 
debi l i ta t ing condi t ion . 
T h e physicians carry out 
the i r evaluations us ing 
sophisticated tests, and 
are par t icular ly focused 
o n those most l i k e l y to 
develop the disease: 
w o m e n . 
"We're t r y i n g to provide an 
inte l l igent , m u l t i d i s c i p l i n a r y 
approach to w o m e n of a l l ages to 
help t h e m m a i n t a i n a heal thy 
ske le ton , " says M i c h a e l F. H o l i c k , 
Ph.D. , M . D . , director of the Group's 
Bone H e a l t h Care Center, and an 
in terna t iona l ly recognized investiga-
tor of v i t a m i n D deficiency related to 
osteoporosis. " W e w o r k w i t h staff 
f r o m n u t r i t i o n , social services and 
physical therapy to give patients 
i n f o r m a t i o n o n dietary requirements, 
as w e l l as the types of activit ies and 
exercises they can do to help t h e m -
selves. 
" W e believe that early diagnosis 
and i n t e r v e n t i o n is key to prevent ing 
or m i n i m i z i n g the consequences of 
the disorder," he says. 
Osteoporosis results f r o m a 
dramatic loss of c a l c i u m and 
collagen m a t r i x f r o m the 
hones, and is an abnormal 
extension of a process that 
At age 40 occurs n o r m a l l y i n a l l 
there are People as they age. 
D u r i n g aging, the bones 
undergo a decrease i n bone 
mass, leading to decreased 
density and porous, t h i n , 
weak bones. Th is process, 
called demineral izat ion, 
makes bones susceptible 
to fractures, part icular ly 
those of the vertebrae 
(back), wr is ts or hips. I t 
often causes loss i n height 
and deformities of the 
back. 
T h e c o n d i t i o n does 
develop i n b o t h m e n and 
w o m e n , generally over the 
age of 50, h u t the process 
and dramatic onset of 
osteoporosis is more 
no 
notice-
able 
effects of 
osteoporosis. 
pronounced i n w o m e n , and generally 
sets i n as a result of menopause-
related bone loss. I t develops i n 25 
percent of a l l w o m e n over the age of 
45, and i n 90 percent of w o m e n over 
the age of 75. 
Osteoporosis is less c o m m o n and 
slower to develop i n m e n because 
they start out w i t h more hone mass 
t h a n w o m e n and lose i t at a m u c h 
slower rate. Some 15 percent of m e n 
at age 90 suffer a h i p fracture as a 
result of osteoporosis, compared to 
25 to 30 percent of w o m e n . 
Role of nutrition 
For most w o m e n , t a k i n g steps early 
on i n l i fe to prevent the onset of 
osteoporosis means developing 
l i fe long n u t r i t i o n a l and l i festyle 
habits that w i l l provide t h e m w i t h 
enough c a l c i u m and v i t a m i n D to 
offset the 
deficiencies 
that occur as 
a result of 
n o r m a l aging. 
Unless a 
y o u t h has a 
strong f a m i l y 
h is tory of the 
disorder, 
adhering to 
these guide-
lines should 
be sufficient, 
according to 
H o l i c k . 
"There is 
ample 
evidence 
demonstrat-
ing that i f a 
w o m a n 
increases her 
c a l c i u m 
intake years 
At 60, 
there is a 
slight 
decrease 
in height 
and 
curvature 
of the 
spine. 
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before menopause—starting f r o m 
ch i ldhood and c o n t i n u i n g t h r o u g h 
her 30s and 40s, she can substantial ly 
increase her bone-mineral dens i ty , " 
he says. 
"We recommend hetween 800 to 
1,000 m i l l i g r a m s of c a l c i u m dai ly for 
adolescent girls and w o m e n up to the 
age of 45 to 50; for w o m e n over the 
age of 50, the in take should be 
increased to more t h a n 1,200 m i l l i -
grams each day," he says. A n 8-
ounce glass of s k i m m i l k contains 
300 m i l l i g r a m s of ca l c ium, as does a 
T u m s EX tahlet. " I f a w o m a n can 
tolerate m i l k , she should d r i n k t w o 
to three glasses dai ly . If she prefers 
to d r i n k just one glass, she can sup-
p lement her in take w i t h t w o or three 
T u m s EX tablets or one of the many 
c a l c i u m supplements that are sold i n 
pharmacies and supermarkets." 
A deficiency of v i t a m i n D , w h i c h 
plays an i m p o r t a n t role i n the 
absorption of ca lc ium, can cause and 
exacerbate osteoporosis by accelerat-
i n g the rate of bone loss. " A w o m a n 
w i t h inadequate levels of v i t a m i n D 
cannot minera l ize bone, so al l that's 
left is a mbbery structure that 
provides no s tructura l support , " 
H o l i c k explains. " I f y o u have 
osteoporosis and porous bone, and 
the new bone you're lay ing d o w n 
cannot be calcified, i t ' s obvious that 
the n e w hone is going to he of l i t t l e 
or no benef i t , " he says. 
M a i n t a i n i n g the hody's natura l 
store of v i t a m i n D is not ord inar i ly a 
concern for people w h o spend t i m e 
outdoors, because casual exposure to 
sunl ight creates enough v i t a m i n D 
for storage i n the fat to last through 
the w i n t e r . I t is a greater issue i n 
elderly w o m e n , w h o may not get 
enough sun exposure through fear of 
w r i n k l e s or s k i n cancer, or an 
i n a b i l i t y to leave their homes. 
"We conducted a study at a local 
nursing home, w h i c h revealed that 
80 percent of the residents were 
borderl ine to overt ly v i t a m i n - D 
def ic ient , " H o l i c k says. For people 
w h o aren't gett ing adequate sun 
exposure—which means being i n 
sunl ight three t imes a week for 15 
m i n u t e s — H o l i c k recommends a 
dai ly m u l t i v i t a m i n conta ining 400 
u n i t s of v i t a m i n D . 
Early intervention 
A l l w o m e n 
approaching 
menopause 
should be 
evaluated to see 
whether they 
should be placed 
on hormone-
replacement 
therapy to 
prevent meno-
pausal bone loss. 
For those people 
e x h i b i t i n g the 
symptoms of 
osteoporosis, 
such as a 
decrease i n 
height, fractures 
of the vertebrae, 
wris ts or hips, or for those w h o have 
a f a m i l y h is tory of the disease, an 
evaluat ion is par t i cular ly advised. 
" I f w e have a pat ient approaching 
menopause w h o has a his tory of a 
m o t h e r or older sister losing several 
inches of height at the age of 60 or 
70, there is concern that she is at 
r i sk for developing osteoporosis," 
says H o l i c k . A n evaluat ion also is i n 
order for w o m e n — a n d m e n — t a k i n g 
steroid medicat ions for the treat-
m e n t of asthma or other condit ions, 
because steroids acceler-
ate the process of hone 
loss. 
For those w h o have 
already begun to 
develop the signs of 
bone deterioration, or 
osteoporosis, there are 
treatments that can 
w o r k to stal l or deter 
further onset. 
Early detection is 
key to prevent ing or 
m i n i m i z i n g the 
consequences of the 
disorder, w h i c h occurs 
i n a l l people to some 
degree by the t i m e 
menopause begins. 
"Even before a w o m a n 
reaches menopause, as 
her hormones begin to 
decline, she w i l l lose 2 
to 3 percent of her 
A dual energy, x-ray oone densitometer, like the one showi. 
procedure above, is used to determine a person's bone density by 
measuring tbe calcium content in tbe lumbar spine and hip. The 
procedure is being conducted by research assistant Adrian Turner. 
bone-mineral density each year," 
says H o l i c k . " I f i t takes t w o or three 
years to f inal ize menopause, a 
w o m a n can lose up to 9 percent of 
her bone density before even start ing 
menopause." 
However, he notes, " T h e c a l c i u m 
a w o m e n has 'stored u p ' i n her 
skeleton t h r o u g h her earlier years as 
a result of proper n u t r i t i o n , exercise 
and not smoking , can help prevent 
the ravages of osteoporosis f r o m 
developing post-menopausal ly ." 
Technology measures 
hone density 
Physicians i n the Bone 
H e a l t h Care Center use 
a number of sophisti-
cated pieces of equip-
m e n t to evaluate 
specific aspects of bone 
mass and thus deter-
m i n e a person's propen-
si ty to develop the 
disease or her r isk for 
suffering h i p and spinal 
fractures. 
A dual energy, x-ray 
bone densitometer, 
w h i c h registers accuracy 
to w i t h i n 1 and 2 
percent, is used to 
determine a person's 
bone density by measur-
ing the c a l c i u m content 
i n the l u m b a r spine and 
By 70, 
fractures 
to the 
spine 
have 
caused 
severe 
damage. 
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h i p . " W e can test a wom an ' s hone 
density and let her k n o w where she 
is relative to someone her o w n age," 
says H o l i c k . "By f o l l o w i n g her every 
one or t w o years, w e can t e l l her at 
w h a t rate she's losing bone, and 
begin to advise her about dietary and 
other l i festyle changes, such as doing 
weight-bearing exercise, w h i c h can 
increase bone mass. We also can 
take a more aggressive approach, 
such as hormone-replacement or 
other d m g therapy, i f she is losing 
bone at a rapid rate . " 
Later th is spring, the Bone H e a l t h 
Care Center w i l l introduce a n e w 
state-of-the-art peripheral quanti ta-
t ive computer tomography (PQCT) 
densitometer, w h i c h w i l l enahle 
physicians to examine the difference 
i n hone density between the trahecu-
lar, the " h o n e y c o m b " part of the 
hone, and the cort ical bone, w h i c h is 
the hard outer w rapping that gives 
bone some of i ts s t m c t u r a l strength. 
I n addi t ion , physicians w i l l be able 
to measure the density of a person's 
hone m a r r o w using the P Q C T 
densitometer. " T h i s machine w i l l 
give us the a h i l i t y to scan the h i p 
and spine separately and more 
q u i c k l y t h a n before," says H o l i c k . 
A n o t h e r i m p o r t a n t diagnostic 
t o o l employed hy the c l inic 's 
physicians involves the use of a 
stadiometer, a sophisticated device 
that can measure a person's height 
w i t h i n an accuracy of 0.1 percent. 
" T h i s precis ion is extremely impor -
tant, because a decrease i n height is 
one of the earliest manifestat ions of 
osteoporosis," says H o l i c k . 
Treating the condition 
There are a number of treatments 
current ly being used to treat 
osteoporosis, the most c o m m o n 
being hormone-replacement therapy, 
w h i c h involves using estrogen to 
reduce the rate of bone loss, and 
progestin, to counteract possible side 
effects of estrogen. " I t appears that 
estrogen stops rapid bone loss 
because bone cells are dependent o n 
the h o r m o n e to m a i n t a i n f u l l 
a c t i v i t y , " says H o l i c k . " W h i l e 
estrogen, the 'female horm one , ' is 
not used to treat m e n w i t h 
osteoporosis, there are other treat-
ments available," he adds. 
The therapy's efficacy i n contro l -
l i n g the course of osteoporosis, as 
w e l l as i n re l iev ing menopause-
related symptoms, such as hot 
flashes, p a i n f u l intercourse and 
m o o d disturbances, and reducing a 
w o m a n ' s r i sk of developing cardio-
vascular disease, is wel l -docu-
mented. However , there are as-yet-
inconclusive indicat ions that 
estrogen replacement therapy 
increases the r i sk of endometr ia l 
'If a woman increases her 
calcium intake years before 
menopause—starting from 
childhood and continuing 
through her 30s and 40s, 
she can substantially 
increase her bone-mineral 
density.' 
cancer and a suspicion that i t 
increases a woman ' s r i sk of develop-
ing breast cancer. 
T o reduce the r i sk of endometr ia l 
cancer, the c l in ic administers b o t h 
estrogen and progestin i n synchroni-
zat ion w i t h the m o n t h l y m e n s t m a l 
cycle. " I feel very strongly that i t ' s 
i m p o r t a n t to m i m i c M o t h e r N a t u r e 
by g iv ing h o r m o n e replacements i n a 
cycle, rather than cont inuously , 
a l though i t means that a w o m a n 
continues to menstruate , " explains 
H o l i c k . 
L ikewise , i n an a t tempt to 
m i n i m i z e the poss ibi l i ty of estrogen-
associated breast cancer, H o l i c k 
consults w i t h , and refers patients to, 
the Hospital 's Breast Hea l th Center 
for assessment and m o n i t o r i n g . 
I n par t i cular ly serious cases of 
osteoporosis, hisphosphonate, a d m g 
that i n h i b i t s cells f r o m destroying 
the bone, is administered i n a 
cycl ical fashion along w i t h ca l c ium. 
Promising research 
I n search of even more effective 
treatments, H o l i c k and his col-
leagues are current ly l o o k i n g for 
patients to participate i n a study of a 
third-generat ion of hisphosphonate 
drugs, w h i c h help to retard hone loss. 
The team also has s u b m i t t e d a 
research proposal to develop n e w 
forms of estrogen and new bone-
targeted dmgs that are a imed at 
p r o v i d i n g u n i q u e advantages and 
fewer side effects t h a n those associ-
ated w i t h current preparations on the 
market . 
" W e are also i n v o l v e d i n l o o k i n g 
at w h a t factors contro l v i t a m i n D 
p r o d u c t i o n i n the sk in , i n order to 
understand w h y aging decreases the 
skin's a b i l i t y to make th is v i t a l l y 
i m p o r t a n t v i t a m i n . We also are 
developing indoor l i g h t i n g for the 
elderly that m i m i c s sunl ight so that 
the elderly can produce v i t a m i n D i n 
the i r s k i n w h i l e indoors , " says 
H o l i c k . 
I n addi t ion , H o l i c k and his 
colleagues are developing a n e w f o r m 
of the active v i t a m i n D , a c o m p o u n d 
that H o l i c k discovered 17 years ago. 
The B U M C H group was the f i rs t to 
synthesize the c o m p o u n d i n the 
laboratory for c l in ica l use. T h i s 
hormone has recently been reported 
to reduce bone loss and decrease the 
r i sk of bone fracture i n more t h a n 
600 w o m e n i n N e w Zealand. 
FOR YOUR INFORMATION 
Dr. Holick is 
, director of the 
. Bone Health 
Care Center of 
; the Evans 
. Medical Group ^^ i^j^ ^^  at BUMCH, a 
medicine, 
dermatology and physiology at 
Boston University School of 
Medicine, and chief of the Endo-
crine and Metabolism Division at 
Boston City Hospital. 
For more information on the Bone 
Health Care Center or on programs 
serving the needs of patients w i t h 
other metabolic or bone diseases, 
please call 1-800-842-3648 during 
business hours. 
4 B O S T O N U N I V E R S I T Y M E D I C A L C E N T E R H O S P I T A L 
WOMEN'S HEALTH 
POST-MASTECTOMY BREAST 
RECONSTRUCTION: 
Giving women a psychological edge 
BY KATHRYN C . JONES 
• ^ H j JM e've a l l heard 
H B i t by n o w : 
One out of 
Wm Wm every n ine 
w o m e n i n 
Amer ica , at some p o i n t 
d u r i n g her l i f e t i m e , w i l l be 
t o l d that she has breast 
cancer. C o n f r o n t i n g the 
diagnosis of the disease, and 
dealing w i t h the i n d i v i d u a l 
prognosis, is a woman's 
preeminent challenge. But a 
real, i f secondary, issue is 
often the poss ib i l i ty of 
having to lose one or b o t h 
breasts to mastectomy, a 
treatment o p t i o n chosen by 
most w o m e n i n N e w 
England w i t h early stage 
breast cancer. 
A t Boston U n i v e r s i t y 
Medica l Center/The Univer -
sity Hospi ta l ( B U M C H ) , 
however, the avai labi l i ty of 
i m m e d i a t e post-mastectomy 
breast reconstmct ion enables 
80 percent of mastectomy 
patients to leave here w i t h a 
head start. 
W h i l e i m m e d i a t e recon-
s t r u c t i o n has been techni-
cal ly feasible for years, the Hospi ta l 
is one of the few heal th care faci l i t ies 
i n Boston that can offer the service, 
according to Caspar W . Anastasi, 
M . D . , B U M C H chief of plastic 
surgery. Anastasi credits this 
achievement to the Breast H e a l t h 
Center's m u l t i d i s c i p l i n a r y approach 
to treatment, w h i c h puts an empha-
sis o n coordinating the schedules of 
its physic ians—in this case, surgical 
oncologists and plastic surgeons. 
" O t h e r hospitals are capable," 
says Anastasi . "But , to be honest, 1 
t h i n k the m a i n reason reconstruc-
Breast-cancer patients like BUMCH operating room 
nurse Mary Medeiros, R.N., have benefitted from 
post-mastectomy breast reconstruction. 
t i o n is not done i m m e d i a t e l y else-
where is that i t becomes very 
d i f f i c u l t to coordinate surgeons' 
schedules. We have a m u l t i d i s c i -
p l ined group here. That 's the k e y . " 
Given the options... 
W o m e n w h o undergo mastectomies, 
or the surgical removal of breast 
tissue, have several options for 
dealing w i t h the outcome. They can 
opt to l ive w i t h their n e w shape, 
wear an external prosthesis, or 
undergo reconstructive surgery, 
either i m m e d i a t e l y f o l l o w i n g a 
^ mastectomy or at some later 
1/ p o i n t . 
There are, Anastasi notes, 
some clear-cut cases where 
breast reconstruct ion should 
be delayed u n t i l m o n t h s 
f o l l o w i n g surgery: W h e n the 
mastec tomy patient w i l l 
receive x-ray therapy or 
chemotherapy f o l l o w i n g her 
surgery, Anastasi says he w i l l 
begin the reconstruct ion 
process i m m e d i a t e l y but w i l l 
no t complete i t u n t i l after the 
required treatment . 
There are some physicians 
w h o favor delaying recon-
s t m c t i o n for m o n t h s i n a l l 
cases, though Anastasi says 
he does not see the need. 
"Phi losophical ly , those w h o 
are opposed to immedia te 
recons tmct ion feel i t may be 
more than a w o m a n can 
m e n t a l l y tolerate at one t i m e : 
N o t only does she have to 
w o r r y about the removal , but 
also about the reconstruct ion 
of her breast," Anastasi says. 
I n such cases, other physi-
cians often make any decision 
regarding breast reconstmc-
t i o n for a patient prior to surgery. " I 
don' t go for t h a t , " Anastasi notes. 
" I t a lk to a l l of m y patients w e l l 
before their mastectomies," Anastasi 
says. "1 ask t h e m w h a t they want , 
and, i f they are hesitant, w e w a i t . 
But there is also c o m m o n sense 
i n v o l v e d , " he says. " I f dur ing a 
mastectomy, a w o m a n has lost a lot 
of blood, or more s k i n is removed 
t h a n i n i t i a l l y planned and there m a y 
be d i f f i c u l t y closing the inc is ion , 
then I w i l l decide, r ight there i n the 
operating r o o m , that w e w o n ' t do i t . " 
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'Changing of the guard' 
I n the operating r o o m , after a team of 
surgical oncologists, led by Maureen 
Kavanah, M . D . , completes a 
mastectomy, a n e w team of physi -
cians, led by Anastasi , enters the 
operating r o o m and takes over, 
carrying out a l i t e ra l changing of the 
guard over the operating table. 
W h e n Anastasi arrives on the scene, 
the wo man ' s breast tissue has been 
removed, leaving her pectoralis 
'The permanent implant is a 
bit smaller so that the breast 
hangs, giving it a more 
natural appearance/ 
major muscle exposed. He begins 
the process of reconstmct ion, k n o w n 
as tissue expansion, by insert ing a 
temporary i m p l a n t (expander) i n t o 
the mastectomy area beneath the 
muscle, and f i l l i n g i t par t ia l ly w i t h 
saline, thereby beginning a gradual 
process of expanding the chest 
muscle and s k i n . Th is process is 
carried out over a period of weeks on 
an outpat ient basis. 
The expander, w h i c h resembles 
a deflated bal loon, is f i l l e d w i t h 
saline s o l u t i o n through a valve left 
outside the body. "That ' s w h a t 
makes tissue expansion u n i q u e , " 
says Anastasi . "You 're not t a k i n g 
tissue f r o m the abdomen, you're 
not t a k i n g tissue f r o m the back; 
y o u are s i m p l y t a k i n g tissue that is 
there already and stretching i t 
s l o w l y using the expander." The 
inc i s ion is then closed, leaving the 
w o m a n w i t h "some ful lness , " 
Anastasi says. The procedure 
generally takes about an hour and a 
half, w h i l e the mastectomy itself 
takes about t w o hours. 
Anastasi uses saline—rather 
t h a n s i l i cone—implants for a l l his 
reconstructive procedures, i n part 
because there is less r i sk associated 
w i t h the s o l u t i o n of a saline 
i m p l a n t should there be leakage. 
A p p r o x i m a t e l y one m o n t h after 
the operation, the w o m a n returns 
to the Hospi ta l on an outpat ient 
basis to have the expander f i l l e d , 
through the valve, w i t h more 
saline, a process she repeats several 
t imes . " T h e expander stretches the 
s k i n and the muscle l i k e a preg-
nancy , " Anastasi says. The patient 
subsequently returns to have the 
i m p l a n t f i l l e d every week u n t i l the 
s k i n is stretched a l i t t l e beyond the 
desired size of the breast. 
Af ter the desired size has been 
attained, the w o m a n returns to the 
operating r o o m for her second and 
f i n a l surgery, where the expander is 
removed and a permanent i m p l a n t is 
p u t i n t o place. " T h e permanent 
i m p l a n t is a h i t smaller so that the 
breast hangs, g iv ing i t a more natura l 
appearance," Anastasi says. 
The f i n a l step i n the process, if a 
w o m a n so chooses, is the reconstruc-
t i o n of the nipple , w h i c h is carried 
out using local s k i n tissue and s k i n 
grafts f r o m the groin . 
The average t i m e required to 
complete the entire process of 
mastectomy, expansion and recon-
s t ruc t ion is about six m o n t h s . 
Th is ambi t ious reconstmct ive 
approach is just one example of the 
m u l t i d i s c i p l i n a r y , comprehensive 
service offered hy the Hospital 's 
Breast H e a l t h Center (see sidebar). 
The following series of illustra-
tions shows the process of 
breast reconstruction from the 
initial stage following 
mastectomy (drawing ffl), to the 
insertion of tbe tissue expander 
underneath the pectoralis major 
(chest) muscle (drawing #2), to 
tbe placement of the permanent, 
saline implant (drawing #3). 
The final stage of tbe process 
involves tbe reconstruction of 
tbe nipple, which is shown in 
place (dr^winn #4 j 
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B U M C ^ s 
BREAST 
HEALTH 
CENTER 
With the number of breast-cancer 
cases in the United States growing at 
an alarming rate, the need for women to 
maintain the health of their breasts is 
more important than ever. The Breast 
Health Center at Boston University 
Medical Center/The University Hospital 
has responded to that need, bringing 
together a multidisciplinary staff of 
general internists, surgical and medical 
oncologists, pathologists, radiologists 
and plastic surgeons dedicated to the 
increasing number of issues associated 
with breast health. 
The Center's mission is to provide 
easily accessible, personal, educational 
and comprehensive care to women, 
focusing on the health—as well as the 
diseases—of the breast. Perhaps the 
most significant component of the 
Center is that its core staff is composed 
of female physicians—four in all—who, 
together, founded the program in 1989. 
Core team members are surgical 
oncologist Maureen Kavanah, M.D., 
medical oncologist Marianne Prout, 
M.D., and Risa Burns, M.D., and Karen 
Freund, M.D., both internists in the 
Women's Health Group. 
In response to the growing demand 
for its services, the Breast Health 
Center recently expanded its hours to 
include Monday mornings. It is also 
open all day on Thursdays. Women 
interested in making appointments 
should call 1-800-848-4808. 
w h i c h reflects a genuine c o m m i t -
m e n t to w o r k i n g w i t h patients f r o m 
their pr imary evaluations through 
any medical consultat ion or treat-
m e n t they m i g h t need. 
One patient's Story 
B U M C H operating r o o m nurse M a r y 
Medeiros, R . N . , learned f i rs thand 
h o w h e l p f u l the Breast H e a l t h 
Center team was, and h o w comfort-
i n g immedia te hreast reconstruct ion 
could be. T h o u g h Anastasi and the 
Breast H e a l t h Center team have been 
per forming immedia te reconstruc-
t ions for almost f ive years, Medeiros 
had never observed the procedure i n 
her four years as an OR nurse. T h a t 
changed last summer, w h e n she was 
forced to face her o w n need for a 
mastectomy. 
Last lune, having previously had a 
l u m p e c t o m y i n her r ight breast, 
Medeiros, 59, was diagnosed w i t h 
i n f i l t r a t i n g duct i le cancer i n the 
same breast. She had t w o options for 
t reatment : One was to have another 
l u m p e c t o m y , i n c l u d i n g removal of 
the l y m p h nodes i n the armpi t , and 
radiat ion w i t h the poss ibi l i ty of 
chemotherapy; the other was to have 
a t o t a l mastectomy. Because she has 
emphysema, she chose not to opt for 
the m e t h o d that w o u l d require 
radiat ion because of the b u r n i n g and 
scarring i t w o u l d cause to her already 
i r r i ta ted lungs. 
As is the case w i t h a l l Breast 
H e a l t h Center patients, Medeiros 
was given a f u l l explanat ion of the 
reconstruct ion options that w o u l d be 
available to her f o l l o w i n g her 
mastectomy. Learning about 
i m m e d i a t e breast reconstruct ion was 
a pleasant surprise for her. " I d idn ' t 
k n o w about the tissue expander," 
she says. " I thought i t was a great 
idea. I wanted to learn m o r e . " 
Because she had never had the 
occasion to observe the procedure, 
Anastasi i n f o r m e d her of his next 
operation and suggested that she 
assist, h o l l o w i n g that surgery, 
Medeiros t o l d her doctors that she 
wa nt ed to have immedia te breast 
reconstruct ion. " [The physicians at 
the Breast H e a l t h Center] explained 
everything to me and made sure I 
understood. By the t i m e 1 was ready 
for surgery, 1 was confident that I 
was doing the r ight t h i n g , " she said. 
Medeiros underwent surgery i n 
July, and was i n the Hospi ta l for less 
t h a n a week f o l l o w i n g the 
mastectomy and tissue expansion. 
She describes the subsequent 
outpat ient process of having the 
expander f i l l e d as being on ly s l ight ly 
uncomfortable . " I was always aware 
of i t being there, but i t caused l i t t l e 
p a i n , " she says. O n N o v . 24, she 
underwent the f i n a l stage of recon-
struct ive surgery, having the ex-
pander replaced w i t h the permanent 
saline i m p l a n t . " T w o weeks later, I 
was feeling good already," she says. 
So good, i n fact, that Medeiros was 
hack w o r k i n g before Christmas. 
Until there is a cure 
The number of i m m e d i a t e breast 
reconstmct ive procedures performed 
has g r o w n i n the f ive years that the 
Hospi ta l has offered the opt ion . " W e 
have gone f r o m per forming one or 
t w o a year to t w o or three a m o n t h , " 
says Anastasi , acknowledging, 
however, that the increase m a y be 
due i n part to the increase i n the 
number of cases of breast cancer. 
Anastasi says he hopes that as 
long as mastec tomy remains an 
approach to breast-cancer treatment , 
the m e t h o d of i m m e d i a t e tissue 
expansion w i l l be used increasingly 
hy hospitals. "Psychological ly , " he 
says, " I t h i n k i m m e d i a t e breast 
reconstmct ion takes a negative 
feeling that w o m e n have about 
mastec tomy—that they are losing 
something—and turns i t i n t o 
something more posit ive. W i t h the 
tissue expander, w o m e n feel that 
something is being done to restore 
their n o r m a l appearance." 
FOR YOUR INFORMATION 
Dr. Anastasi is 
chief of the 
Department of 
Plastic and 
Reconstructive 
Surgery and is a 
clinical 
professor of 
surgery at 
Boston University School of 
Medicine. 
For more information on breast 
reconstruction or on other plastic 
surgery or reconstructive services 
offered at the Hospital, please call 
1-800-842-3648 during business 
hours. 
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Hysteroscopy and 
laparoscopy provide 
new opportunities 
in gynecology 
BY CYNTHIA L . LEPORE 
f
r o m her college years 
onward, Arlene Ash , 
Ph.D., 46, was plagued 
by m e n s t m a l cramps so 
severe that they some-
t imes caused her to lose conscious-
ness. But l i k e m i l l i o n s of w o m e n . 
A s h f o u n d relief f r o m the recurring 
pain i n a bot t le of ibuprofen. T h e n 
t w o years ago, she began experienc-
ing unusual ly heavy menstrual 
bleeding, a c o n d i t i o n experienced by 
as m a n y as 30 percent of w o m e n of 
reproductive age. H o p i n g the 
bleeding was related to menopause. 
A s h p u t up w i t h the prob lem for 
several m o n t h s u n t i l her symptoms 
grew increasingly worse. 
"That ' s w h e n I decided I had to 
deal w i t h i t , " she says. 
A member of the H e a l t h Care 
Research U n i t at Boston U n i v e r s i t y 
Medica l Center/The U n i v e r s i t y 
Hospi ta l ( B U M C H ) , A s h ended up i n 
the office of a colleague, Robert M . 
Weiss, M . D . , director of reproductive 
endocrinology and i n f e r t i l i t y . Weiss 
is one of only a few physicians i n 
Boston w i t h expertise i n operative 
hysteroscopy, an outpat ient surgical 
procedure that enables a physic ian to 
evaluate and treat abnormalit ies 
inside the uterus. 
W h i l e hysteroscopy is not a new 
technique, recent advances i n its 
i n s t m m e n t a t i o n have expanded the 
ways i n w h i c h i t can he used as a 
corrective therapy: The technique is 
n o w being employed here as the 
approach of choice to detect and 
correct a w i d e range of c o m m o n yet 
debi l i ta t ing gynecologic disorders, 
f r o m abnormal m e n s t m a l bleeding 
to i n f e r t i l i t y . The good news for 
patients is that hysteroscopy, l i k e a 
number of other endoscopic proce-
dures n o w being performed r o u t i n e l y 
by B U M C H surgeons, can be accom-
plished w i t h less trauma, less 
recovery t i m e and less cost than 
t rad i t iona l surgery. A n d w h e n i t is 
used as a diagnostic too l , 
hysteroscopy can he performed i n 
the doctor's office. 
" I n the case of a pat ient where 
the cause of pain or bleeding is not 
clear, or where the patient does not 
respond to medical management, a 
hysteroscopy may be h e l p f u l i n 
obta ining a f u l l and comprehensive 
eva luat ion , " says Weiss, w h o 
received special i n s t r u c t i o n i n using 
the technique dur ing his post-
graduate t ra in ing . 
Such was the case w i t h Ash , for 
w h o m Weiss could f i n d n o t h i n g 
pathological ly w r o n g after t a k i n g a 
biopsy of her uter ine tissue. Even a 
three -month regimen of Provera, a 
hormone c o m m o n l y prescribed to 
decrease unusual ly heavy bleeding, 
failed to correct the undiagnosed 
problem. 
That diagnosis came q u i c k l y and 
effortlessly w i t h i n only m i n u t e s of 
beginning che procedure. Us ing the 
hysteroscope, a long, t h i n , f lexible 
scope that is inserted i n t o the utems 
via the vagina, Weiss was able to 
visualize the inside of the u tems on 
a video m o n i t o r and determine the 
source of his patient's bleeding—a 
large, noncancerous, f i b r o i d t u m o r , 
located on the uterine w a l l . Ash, 
w h o was awake throughout the 
entire procedure, was able to observe 
the t u m o r . " I t was amazing to see 
this large bulbous g r o w t h i n l i v i n g 
color , " she said. " I was fascinated by 
the w h o l e t h i n g . " 
Before hysteroscopy was avail-
able, a d i l a t i o n and curettage ( "D &i 
C") performed i n the operating r o o m 
was the pr inc ipa l w a y to evaluate 
the causes of abnormal bleeding. 
T h o u g h i t s t i l l remains a viable 
diagnostic technique used by m a n y 
gynecologists today, the D &i C may 
f a i l to diagnose up to 35 percent of 
submucous uterine f ibroids ( tumors 
located inside the uterus) and polyps 
as the source of bleeding problems, 
says Weiss. 
Hysteroscopy=fewer hysterectomies 
As recently as f ive years ago, a 
w o m a n w i t h symptomat i c f ibroids 
almost always ended up w i t h a 
hysterectomy, a f u l l - b l o w n surgical 
procedure i n w h i c h the utems is 
removed, thereby prevent ing the 
possibi l i ty of pregnancy. I n sharp 
contrast to the endoscopic approach. 
Using the hysteroscope, Hospital 
gynecologists are able to detect and treat 
abnormaltles Inside tbe uterus. During an 
I no ffIce examination, Robert Weiss, M.D., 
above, points out a noncancerous, uterine 
fibroid to a patient. 
a hysterectomy usual ly requires 
spending four to seven days i n the 
hospital and up to six weeks recuper-
at ing at home. I n opt ing for a 
hysteroscopy. A s h also was spared 
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another major operation, called 
abdominal m y o m e c t o m y , a proce-
dure that involves opening up the 
ahdomen, excising the fibroids and 
leaving the uterus intact . 
W i t h the aid of the hysteroscope 
and a c u t t i n g at tachment k n o w n as a 
resectoscope, Weiss and his surgical 
t ea m removed the f ibro id . The 
entire operation, w h i c h took about 
90 minutes , was performed o n a 
Friday. T h o u g h w o m e n w i t h smaller 
f ibroids usual ly can go home that 
same day. Ash—whose f i b r o i d was 
between three and four centimeters 
large—remained i n the hospital 
overnight for observation and was 
discharged the next m o r n i n g . She 
was back at w o r k on Monday. Since 
her surgery, the abnormal bleeding 
has stopped. 
Because of the large size of her 
f ibro id . A s h was given injections of a 
new d m g six weeks pr ior to her 
surgery that shrinks b o t h the f ibroids 
and the surrounding tissue to 
provide a better v i e w of the t u m o r 
d u r i n g surgery. Called Lupron, the 
drug is being tested i n the B U M C H 
Depar tment of Gynecology as part of 
a m u l t i c e n t e r study that w i l l 
determine its usefulness as an 
adjunct to m y o m e c t o m y . Already 
FDA-approved for use i n treat ing 
endometriosis, L u p r o n appears to 
halt the product ion of estrogen, thus 
denying the f ibroids the nour ish-
m e n t they need to grow. 
W h i l e hysteroscopy is also being 
employed by B U M C H gynecologists 
to detect and treat polyps and some 
cases of i n f e r t i l i t y , i t also is used to 
per form endometr ia l ablations. Th is 
outpat ient surgical procedure, also 
an alternative to hysterectomy, is 
considered suitable for treat ing 
abnormal uter ine bleeding or severe 
m e n s t m a l pa in for w h i c h there is no 
apparent cause. However, because i t 
results i n the permanent suppression 
of m e ns t rua t ion i n 80 percent of 
cases, i t is reserved for w o m e n w h o 
do not w i s h to have chi ldren. 
D u r i n g an endometr ia l ablation, a 
physic ian uses the hysteroscope and 
a ro l lerbal l i n s t r u m e n t to cauterize 
the l i n i n g of the utems, or endome-
t r i u m , thus prevent ing the m o n t h l y 
" shedding" of the uterine l i n i n g . 
Laparoscopy: safe and versatile 
H i g h l y regarded for its safety and 
versat i l i ty , laparoscopy is yet 
another surgical approach being 
taken by Hospi ta l gynecologists to 
excise f i b r o i d tumors located outside 
the utems, to remove and repair 
damaged fa l lopian tubes and ovarian 
cysts, to treat endometriosis, and to 
assist i n vaginal hysterectomies. 
I n a relat ively n e w technique, 
B U M C H gynecologist Ginter Sotrel, 
M . D . , is using the laparoscope to 
reverse s ter i l izat ion i n w o m e n . 
Ster i l izat ion is a surgical procedure 
that involves the c u t t i n g of a 
woman 's fa l lopian tubes i n order to 
prevent conception. 
Previously, the intr icate process 
of reconnecting the fa l lopian tubes 
could on l y be accomplished through 
major surgery, typ ica l ly necessitating 
a four- to s ix - inch abdominal 
inc is ion, three to four days i n the 
hospi ta l and up to a m o n t h of 
recuperation. The advantage of 
laparoscopy is that i t requires only 
four t i n y incisions, requires no 
hospi ta l izat ion and decreases the 
patient 's recovery t i m e to three to 
four days. 
The entire operation, w h i c h takes 
about three to four hours, is con-
ducted through the incisions, w i t h 
one port being reserved for the 
laparoscope, a second for a carbon 
dioxide laser and the remain ing t w o 
for other surgical ins t ruments . W i t h 
the aid of the laparoscope to visual-
ize the inside of the abdomen and 
the tubes, Sotrel uses the laser to 
transect and open the tubes then 
reconnect t h e m by microscopical ly 
sutur ing the open ends together, thus 
enabling the passage of the egg to the 
utems. 
The other major benefit of the 
laparoscopic reversal, says Sotrel, is 
its cost, w h i c h is about three t imes 
less expensive to per form t h a n open 
surgery. Th is comes as welcome 
news for patients w h o m u s t pay for 
the elective procedure out of pocket 
because i t is not reimbursable by 
medical insurance. 
FOR YOUR INFORMATION 
Dr. Weiss is 
director of 
reproductive 
endocrinology 
and inferti l ity 
and is an 
assistant 
professor of 
obstetrics and 
gynecology at Boston University 
School of Medicine. 
Dr. Sotrel is a 
member of the 
Department of 
Gynecology 
and is an 
associate 
professor of 
obstetrics and 
gynecology at 
the School of Medicine. 
For more information on gyneco-
logic hysteroscopy or laparoscopy or 
on other gynecologic services 
offered at the Hospital, please call 1-
800-842-3648 during business hours. 
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WOMEN'S HEALTH 
Women and Aging 
Preparing will help ensure they really are 'golden years' 
A 
As America 
continues to 
age, ttie healtti 
care commu-
nity and the 
tederal 
government 
will be taced 
with the 
daunting 
challenge at 
caring tor an 
elderly 
population that is expected to reach 70.5 
million by the year 2050. For the most part, 
this population will be composed ot elderly 
women, who, by age 65, can expect to live 
another 18.6 years—tour more years than 
men. 
In the tollowing interview, Fatricia F. 
Barry, M.D., the new chiet ot geriatrics 
and director otthe Home Medical Service 
at Boston University Medical Center/The 
University Hospital (BUMCH), and the 
director ot Boston University's Gerontol-
ogy Center, shares her views on a variety 
ot topics attecting women and aging, and 
discusses the impact ot home-care 
programs on the quality otiite tor older 
Americans, in general. 
Progress: I t has been well-docu-
mented that although w o m e n live 
longer than men, they do not 
necessarily l ive better because they 
are prone to chronic debil itating 
diseases. What is being done to 
address this phenomenon? 
Barry: I n geriatric medicine, a great 
deal of emphasis is placed on t ry ing 
to maximize funct ion and m i n i m i z e 
disability due to chronic disease i n 
older people, particularly older 
women. Some of the ways i n w h i c h 
we can achieve this goal entail 
opt imizing the physical health of 
the elderly, preventing disability, 
and providing them w i t h the 
services they need to remain 
independent i n their homes, 
including rehabilitation. 
Progress: Many w o m e n today aged 65 
and older are "home alone"—that is, 
they are three-and-a-half times more 
l ikely to be widowed than men, and 
are more l ike ly to end their lives i n 
nursing homes. What are some 
preventive measures that w o m e n can 
take early i n life to enable them to 
live healthier later? 
Barry: We could try to help men to 
live longer, and I ' m not being face-
tious. Act ively work ing to help men 
l ive longer w o u l d help women 
because i t w o u l d give them compan-
ionship and support i n old age. In 
terms of what w o m e n can do to age 
better, the obvious answer is that they 
can take better care of themselves 
when they are young. Mainta in ing an 
active lifestyle, not smoking, eating 
wel l , dr inking only i n moderation, and 
undertaking good preventive medi-
cine, including screening for hyperten-
sion and breast and other cancers, can 
better prepare women for their golden 
years. Staying f i t mental ly is also 
important, as is staying involved w i t h 
fami ly and communi ty . There is no 
question that successful aging does 
require some effort. But i t generally 
pays off, and those who make a 
concerted effort early on i n life are the 
ones who tend to remain healthier as 
they age. 
Progress: What are some of the 
special medical problems facing older 
women? 
Barry: The leading cause of death i n 
older women right now is actually 
cardiovascular disease. Though we 
have been led to believe that heart 
disease strikes only middle-aged men, 
i t is an equally important disease of 
older, post-menopausal women. 
A r t h r i t i s is also another disease that 
causes a great deal of disability i n 
older women. The musculoskeletal 
diseases, i n general, are the leading 
cause of functional disability i n the 
elderly. Osteoporosis is also a 
significant problem i n older women. 
Though older men also can develop 
this condition, i t is pr imar i ly associ-
ated w i t h women, who, because they 
have smaller bone mass, are more at 
risk particularly after menopause. 
Progress: The 14-year, $625-mil l ion 
Women's Health Initiative, the 
largest cl inical study ever under-
taken i n this country, is aimed 
specifically at women's health i n 
their last t h i r d of life. However, i t 
has been criticized by some who say 
i t w i l l not adequately address tbe 
health issues of al l women, particu-
larly those f rom m i n o r i t y and poor 
and low-income segments of the 
population. As a researcher and a 
clinician, do you have fa i th that such 
an endeavor w i l l bear fruit? 
Barry: This study should answer 
some very important questions 
about the use of estrogen and its 
efficacy i n risk reduction for cardio-
vascular disease and osteoporosis, as 
w e l l as its role i n breast cancer, 
endometrial cancer and other 
diseases. I t also should shed l ight on 
the differential risk factors of various 
racial and socio-economic groups of 
w o m e n for disabling or lethal illness. 
Progress: The Home Medical 
Service has been providing home 
care to Boston's elderly for more 
than 115 years. As health care costs 
continue to spiral, i t w o u l d seem 
that home-care programs are a more 
cost-efficient approach to providing 
care than hospitalization or nursing 
homes. 
Barry: W i t h o u t a doubt, home care 
is less costly than hospitalization. 
Whether i t is less costly than nurs-
ing home care is not as clear. Unfor-
tunately, this becomes a question of 
whether as a society we let cost 
determine the type of services to be 
provided. Of interest is that we 
don't always do that i n other areas of 
health care i n this country. 
I n general, I t h i n k that home care 
offers tremendous benefits i n terms 
of patient-related quality of life. 
Most people are better off if they 
remain at home, and that's what 
they prefer. 
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WOMEN'S HEALTH 
' A r e 
G i v e n Amer ica ' s love affair w i t h food and i t s obsession w i t h the w a i s t l i n e , i t ' s n o t surpris ing tha t 
m i l l i o n s of A m e r i c a n s — m o s t 
of t h e m females—fal l v i c t i m 
each year to eating disorders. 
"We 're dealing w i t h a society 
tha t puts m u c h m o r e pressure 
o n w o m e n n o t o n l y to be of 
n o r m a l w e i g h t , b u t to be 
u n d e r w e i g h t , " says Karen M . 
Freund, M . D . , d i rec tor of the 
W o m e n ' s H e a l t h G r o u p at 
Boston U n i v e r s i t y M e d i c a l 
Center/The U n i v e r s i t y Hospi -
t a l ( B U M C H ) . 
Recogniz ing the frequency 
and severi ty of eating disor-
ders, Freund and her colleagues 
at the Women ' s H e a l t h Group 
are w o r k i n g to address the 
issue more closely i n the 
p r i m a r y care sett ing. 
Focusing the i r a t t e n t i o n o n 
detect ion, they have developed 
a screening t o o l that invo lves 
s i m p l y asking t w o questions, 
y o u satisfied w i t h y o u r eat ing 
patterns?" and " D o y o u ever eat i n 
secret?," tha t physic ians can use as 
a w a r n i n g of b u l i m i a . Character-
ized by binge eat ing f o l l o w e d by 
se l f - induced v o m i t i n g or the use of 
laxatives to counteract w e i g h t gain, 
the c o n d i t i o n is bel ieved to affect 
some 3 percent of a l l U.S. w o m e n 
hetween the ages of 14 and 40. 
" T h e challenge w i t h b u l i m i a is 
t h a t a person doesn't e x h i b i t any 
obvious phys ica l signs because she 
o f t e n appears to he of n o r m a l or 
even above-normal w e i g h t , " says 
Freund. " F v e n the medica l c o m p l i -
cations t h a t can resul t f r o m 
b u l i m i a , such as a sore throat or 
gas tro intes t ina l bleeding, m a y n o t 
he l i n k e d w i t h the disorder because 
the problems are so non-specif ic i n 
n a t u r e . " 
A n o t h e r factor t h a t makes 
b u l i m i a so cha l lenging to diagnose, 
Freund says, is tha t i t s sufferers are 
ex t remely embarrassed and secre-
t i v e about t h e i r binge-and-purge 
behavior. H o w e v e r , because they 
are capable of f u n c t i o n i n g n o r m a l l y . 
DETECTING BULIMIA 
Two key questions help patients 
confront a difficult situation 
b u l i m i c s o f ten struggle w i t h the 
i l lness for f ive to 10 years before 
they seek t re a tme nt . " T h i s is n o t 
s o m e t h i n g that a w o m a n w i l l 
readi ly w a l k i n w i t h and say, 'Hey, 
t h i s is a p r o b l e m , ' " says Freund. " I t 
therefore requires a sensit ive 
phys ic ian w h o is t u n e d i n to 
b u l i m i a as a p o s s i b i l i t y and a 
pat ient w h o feels t r u s t i n g enough of 
that provider to begin to disclose 
her s i t u a t i o n . " 
I n a B U M C H study publ i she d i n 
the M a y issue of the Journal of 
General Internal Medicine, a t e am 
of researchers, led by Freund, f o u n d 
tha t the t w o s imple questions 
referred to above m a y be as effective 
as a m o r e extensive quest ionnaire 
i n i d e n t i f y i n g w o m e n w i t h eat ing 
disorders. The researchers also 
f o u n d tha t the questions can be 
easily incorporated i n t o the r o u t i n e 
m e d i c a l h i s t o r y obta ined f r o m a l l 
w o m e n . Says Freund, " O u r goal 
was to develop an approach by 
w h i c h physic ians c o u l d i n q u i r e 
about eat ing disorders i n a no n-
threatening m a n n e r . " 
I t is i m p o r t a n t for physicians to 
remember tha t n o t a l l w o m e n w h o 
respond a f f i r m a t i v e l y to these 
questions s h o u l d be labeled 
b u l i m i c , Freund notes. "For 
some w o m e n , a d d i t i o n a l 
que s t io n ing and discussion of 
t h e i r eat ing behaviors is 
ind ica ted to see w h e t h e r fur -
ther e va lua t io n or referral is 
ac tua l ly necessary," she says. 
T h o u g h nearly a l l of the 
b u l i m i c w o m e n p a r t i c i p a t i n g 
i n the s tudy reported seeking 
m e d i c a l a t t e n t i o n for prob-
lems they fe l t were related to 
t h e i r b u l i m i a , m a n y said tha t 
the i r h e a l t h care providers 
were unaware of t h e i r eat ing 
disorder. " T h i s suggests tha t 
w e were successful i n recrui t -
i n g some of the very pat ients 
whose problems r e m a i n 
undetected and w h o m i g h t 
benef i t f r o m screening for 
eating disorders ," says Freund. 
W h i l e the staff of the 
Wo me n ' s H e a l t h G r o u p 
— cont inues to test the effective-
ness of i ts n e w approach, the 
physic ians have f o u n d the tech-
n ique o v e r w h e l m i n g l y successful to 
date. " O u r p r e l i m i n a r y data 
suggests tha t t h i s l i n e of quest ion-
i n g w o u l d be very effective i n 
p r o v i d i n g physic ians w i t h a rapid, 
easy w a y to begin to di f ferent iate 
w o m e n w h o m i g h t have an eat ing 
p r o b l e m , " says Freund. 
Cynthia L. Lepore 
FOR YOUR INFORMATION 
Dr. Freund is 
director of the 
Women's 
Health Group 
and is an 
assistant 
professor of 
medicine at 
Boston 
University School of Medicine. 
For more information on eating 
disorders or on other services 
offered at the Women's Health 
Group, please call 1-800-842-3648 
during business hours. 
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Stem Cells 
to the 
Rescue 
New autologous blood 
therapy shown 
successful in treating 
difficult cancers 
M M new alternative to bone-
M M m a r r o w transplantat ion, 
^^^B i n w h i c h a person's o w n 
^^^^B blood cells rescue the 
" bone m a r r o w after h i g h 
doses of chemotherapy, is being 
tested against certain cancers at 
Boston U n i v e r s i t y Medica l Center/ 
The U n i v e r s i t y Hos p i ta l ( B U M C H ) , 
and is s h o w n to have very favorable 
results. 
Cal led autologous peripheral 
b lood stem-cel l infus ion, this 
therapy involves the drawing of a 
person's s tem cells ( t iny "seed" cells 
f o u n d i n bone m a r r o w and peripheral 
b lood f r o m w h i c h a l l other b lood 
cells form) f r o m the body's periph-
eral b lood supply, freezing the cells, 
and t h e n later t h a w i n g and infus ing 
t h e m to rescue a patient 's bone 
m a r r o w after h i g h doses of chemo-
therapy. 
A t B U M C H , the therapy has 
proven successful i n t reat ing several 
patients w i t h metastatic hreast 
cancer and i t is n o w being used on 
patients w i t h different types of 
l ymphoma s , i n c l u d i n g Hodgkin ' s 
disease. Cancer and blood experts 
here also plan to test this therapy 
against small -cel l l u n g cancer, the 
most aggressive f o r m of l u n g cancer, 
but one that responds w e l l to 
chemotherapy, and to test i t against 
ovarian cancer, and a number of 
other malignancies that are chemo-
therapy sensitive. 
The Autologous Stem C e l l 
Transplant Program, under the 
guidance of i ts director, Evan 
Vosburgh, M . D . , and B U M C Cancer 
Center Direc tor Douglas V. Faller, 
Ph.D., M . D . , ut i l izes the expertise of 
Raymond Comenzo, M . D . , director 
of the Hospital 's Transfusion 
Medic ine Service/Blood Bank, and 
Hos p i ta l medica l oncologists Paul J. 
Hesketh, M . D . , Sualp Tansan, M . D . , 
and H o w a r d Safran, M . D . 
How it works 
T h i s therapy finds i ts roots, l i tera l ly , 
i n the bone m a r r o w . "Auto lo go us 
hone m a r r o w rescue has been s h o w n 
to be very useful i n l y m p h o m a s that 
have not responded to f r o n t l i n e 
therapy or i n cases where the 
l y m p h o m a has recurred," says 
Comenzo, an expert i n such tech-
niques. " F r o m w h a t w e k n o w , 
chemotherapy-sensit ive diseases, i n 
general, should y i e l d a benefit f r o m 
high-dose chemotherapy w i t h stem-
cell rescue. Data also is g r o w i n g to 
support the v i e w that i n certain 
diseases, peripheral b lood stem cells 
m a y be more useful t h a n bone-
m a r r o w stem cells that are contami-
nated by mal ignant cel ls ." 
"Ex t reme ly pre l iminary , i n i t i a l 
results w i t h this approach i n ad-
vanced breast cancer have been 
encouraging," says Hesketh. "Three 
patients have been treated here as 
part of an ongoing study. A l l of 
these patients have completed 
t reatment and are free of a l l signs of 
breast cancer at this t i m e . " 
Stem-cell in fus ion is not a 
therapy i n and of itself, H e s k e t h 
explains. " I t is a m e t h o d for f o r t i f y -
ing the hematopoietic , or b lood-
f o r m i n g , system so that intense 
doses of chemotherapy can be given, 
thus i m p r o v i n g the effectiveness of 
the chemotherapy." 
The f irst step of the therapy, 
k n o w n as " p r i m i n g , " is for patients 
to receive chemotherapy and g r o w t h 
factors, or g r o w t h factors alone, i n 
order to induce the product ion of 
peripheral b lood stem cells (PBSCs). 
The b lood t h e n is d r a w n f r o m the 
pat ient and separated w i t h a pheresis 
machine, us ing a new m e t h o d 
developed by Comenzo called large 
v o l u m e leukapheresis (LVL). 
I n the convent ional me tho d , only 
10 l i ters of b lood are processed to 
harvest PBSCs i n t w o hours, w i t h 
the entire procedure t a k i n g about 
eight hours over a four-day period. 
W i t h LV L, 15 to 35 l i ters of b lood are 
processed i n five hours, w i t h the 
procedure t a k i n g about 10 hours or 
t w o days. " A b o u t two-and-a-half to 
three t imes more cells are collected 
i n the last half of large v o l u m e 
Low-dose chemotherapy plus growth factors 
Remission 
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leukapheresis than i n the f irst , 
possibly because the longer process 
somehow ' recmits ' stem cells f r o m 
the bone m a r r o w , " Comenzo 
explains. Once the cells have been 
collected, the next step is to freeze 
t h e m . U s i n g a chemical preservative 
called d imethy lsu l fox ide (DMSO), 
the cells are stored i n hags and frozen 
at 80 degrees be low zero. 
Af ter patients have received h igh-
dose chemotherapy, the bags are 
brought to the bedside, t h a w e d and 
then i m m e d i a t e l y infused. " T h i s 
product is essentially administered 
to 'rescue' the bone m a r r o w that has 
been k i l l e d by the chemotherapy," 
says B U M C Cancer Center Director 
Faller. T h e therapy also "rescues" 
pat ients f r o m infec t ion and the need 
for m u l t i p l e blood and platelet 
transfusions dur ing the three-to-four-
w e e k period typica l ly f o l l o w i n g 
high-dose chemotherapy w h e n the 
w h i t e blood count is dangerously 
l o w . 
Bone marrow VS. 
peripheral bioodstem ceils 
Because the therapy is so new, 
experts are undecided as to whether 
s tem cells f r o m the peripheral b lood 
are more viable t h a n s tem cells f r o m 
the bone m a r r o w . One advantage of 
peripheral b lood stem cells, some 
physicians say, is that they 
repopulate faster than m a r r o w cells 
and are more " c o m m i t t e d " (dedi-
cated to g iv ing rise to w h i t e cells) i n 
the peripheral blood. Cri t ics , 
however, say that PBSCs m ay " b u r n 
o u t " or not be as c o m m i t t e d after a 
certain period of t i m e . 
" T h e efficacy of these products is 
somewhat di f ferent , " says Vosburgh. 
" M o b i l i z e d peripheral blood stem 
cells engraft rapidly for w h i t e cells 
and platelets i n about 10 days, 
whereas marrow-based cells take 
about 18 days to engraft i n most 
instances." 
A major Atlanta-based study 
compar ing the use of PBSCs and 
marrow-based cells i n w o m e n 
receiving high-dose chemotherapy 
for breast cancer whose m a r r o w 
appeared n o r m a l showed there to be 
no difference i n the t i m e i t takes for 
w h i t e cells to engraft. However, the 
study d i d f i n d an o v e r w h e l m i n g 
difference i n cost, w i t h the expense 
of obta ining peripheral b lood stem 
cells exceeding that of m a r r o w col-
lec t ion by a median of $4,800 per 
patient . 
S t i l l , experts l i k e Comenzo 
contend that there are clear-cut 
indicat ions w h e n PBSCs are more 
beneficial : W h e n there is no bone 
m a r r o w available f r o m w h i c h to 
harvest the cells or w h e n the 
m a r r o w is diseased. 
Debate also exists as to w h i c h of 
the t w o therapies is more tolerable 
to patients. Because harvesting hone 
m a r r o w requires general anesthesia, 
PBSC rescue is generally considered 
more acceptable, par t icular ly for 
patients w h o pose a surgical r isk . 
But w h i l e drawing s tem cells f r o m 
peripheral blood is an outpat ient 
procedure, i t does require a m i n o r 
surgical procedure, conducted under 
local anesthesia, i n w h i c h a central 
venous l ine is inserted just be low a 
patient 's collarbone for use later on 
i n col lect ing and in fus ing the s tem 
cells. 
One downside of PBSC rescue is 
that there is as m u c h as a 20-percent 
incidence of non-engraftment for 
platelets. Concern about this r i sk 
has generated widespread contro-
versy about the co l lec t ion of hone 
m a r r o w as a backup, par t i cular ly if 
the bone m a r r o w is diseased. "There 
can he no quest ion that , f r o m the 
v i e w p o i n t of m a k i n g minuscu le the 
risks for non-engraftment, a backup 
is preferred, whether or not contami-
nat ing mal ignant cells are present," 
says Comenzo. " A t the same t i m e , 
however, a c l in ica l decision has to be 
made whether to subject a pat ient to 
the poss ibi l i ty of m u l t i p l e platelet 
transfusions or to m n the r i sk of re-
establishing the t u m o r . " 
So w h a t can be expected f r o m this 
therapy? Comenzo says that i ts 
success w i t h some cancers could 
mean "a 15- or 20-percent long-term, 
disease-free survival rate. We're not 
going to see large numbers, such as 
an 80- or 90-percent cure rate. But 
w h e n you're faced w i t h a 0-percent 
surviva l rate as an alternative, 20 
percent looks pret ty good." 
Cynthia L. Lepore 
and Michael R. Paskavitz 
FOR YOUR INFORMATION 
Dr. Comenzo 
is director of 
the Transfu-
sion Medicine 
Service/Blood 
Bank and is an 
assistant 
professor of 
pathology, 
laboratory medicine and medicine 
at Boston University School of 
Medicine. 
Dr. Faller is 
:. director of the 
'* ; I Cancer Center 
at Boston 
University 
Medical 
Center and is a 
professor of 
medicine at 
the School of Medicine. 
Dr. Hesketh is 
clinical 
director of the 
Evans Section 
of Medical 
Oncology, 
director of the 
Hospital's 
Lung Cancer 
Center and is an associate professor 
of medicine at the School of 
Medicine. 
Dr. Vosburgh 
is director of 
the Autolo-
gous Stem 
Cell Trans-
plant Program 
and is an 
assistant 
professor of 
medicine at the School of Medi-
cine. 
For more information on the stem-
cell infusion therapy, call 1 -800-
842-3648 during business hours. 
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P R O G R E S S F O L L O W - U P 
This magazine's name, Progress, characterizes the continuing drive by physician researchers at an 
academic medical center to improve patient care and treatment options. The following two stories, 
first reported in Progress in December 1988 and January 1991, show how the early promise of 
two approaches is being realized. 
Human heart 
valves shown 
to outlast 
animal valves 
^^^^^^^^^ ^^ ^^ ^^  ^ ^^ '^^  
tissue than 
h u m a n tissue. But only i n recent 
years, after dealing w i t h the 
p r o b l e m of graft rejection, have 
surgeons begun to substantiate 
that theory. 
One such study, conducted at 
Boston U n i v e r s i t y M e d i c a l Center/ 
T h e U n i v e r s i t y Hospi ta l 
( B U M C H ) , f o u n d that transplanted 
h u m a n heart valves, called 
homografts , are more durable than 
pig (porcine) valves. " A f t e r 10 
years, 90 percent of h u m a n valves 
are s t i l l f u n c t i o n i n g properly, as 
compared to 70 percent of pig 
valves , " says Richard J. Shemin, 
M . D . , B U M C H chief of 
cardiothoracic surgery. 
Valve-replacement surgery is a 
h i g h l y effective m e t h o d of treat-
m e n t for people w i t h serious heart 
condit ions , such as congestive 
heart fai lure and aortic stenosis. I n 
1986, Shemin performed the f irst 
successful cryopreserved h u m a n 
aortic valve transplant i n an adult 
pat ient i n N e w England. 
Since then, he has transplanted 
more t h a n 50 valves, and 98 
percent of his patients are doing 
w e l l today because of the surgery. 
I n fact, some patients w h o for-
m e r l y were unable to w o r k and 
f u n c t i o n n o r m a l l y because of their 
heart c o n d i t i o n n o w lead t o t a l l y 
n o r m a l l ives. " T h e i m m e d i a t e post-
operative benefits of homografts , 
over the other valves, are w e l l -
documented for patients requir ing a 
valve replacement due to in fec t ion of 
the i r heart v a l v e , " points out 
Shemin. " O u r data shows that the 
long- term success rate is greater for 
h u m a n valves compared to pig valves 
w h e n d u r a b i l i t y and the l i k e l i h o o d of 
b lood clots f r o m a valve are consid-
ered." 
The pros and cons 
T h e issue of w h i c h type of v a l v e — 
h u m a n , a n i m a l or m e c h a n i c a l — w i l l 
offer patients the best long- term 
prognosis has been an ongoing source 
of debate among experts for years. 
One major advantage h u m a n valves 
have over the others is that the l i v i n g 
cells that r e m a i n i n the valve a l l o w 
i t to potent ia l ly repair itself after 
transplantat ion, w h i c h is not the 
case w i t h pig or mechanical valves. 
'i His tor i ca l ly , however, h u m a n valves 
have been i n short supply and, u n t i l 
recent years, scientists have not been 
able to store the valves i n a way i n 
w h i c h the l i v i n g cells could he 
m a i n t a i n e d for more t h a n a few days. 
The current methods of preserving 
' the valves i n a frozen or 
cryopreserved state have an indef i -
n i t e storage period. 
A n i m a l valves, meanwhi le , 
i a l though far more available, do not 
have the cellular qua l i ty of h u m a n 
valves. These valves are treated so 
they are not rejected hy the body; 
however, they do wear out over t i m e . 
Mechanica l valves, w h i l e p o t e n t i a l l y 
more durable t h a n either h u m a n or 
i p ig valves, can cause blood clots, 
I w h i c h t h e n require recipients to 
r e m a i n o n a l i fe long regimen of ant i -
! c l o t t i n g medica t ion . 
W h i l e Shemin's research suggests 
that , based on their success, 
I homografts could replace the need 
for pig and, i n some cases, me-
chanical valves, he says tha t w o n ' t 
happen for one simple reason: 
"There aren't as m a n y h u m a n 
valves available as there are 
patients w h o need t h e m . " Thus , 
i n addi t ion to supporting cam-
paigns to attract more organ and 
tissue donors i n the general pop-
u l a t i o n , Shemin is also researching 
ways to i m p r o v e various types of 
a n i m a l and ar t i f i c ia l valves. 
Cryopreservatlon, 
tissue availability are key 
Shemin ascribes the i m p r o v e m e n t 
i n storing h u m a n valves to 
advances i n the w a y the valves are 
preserved. Surgeons are n o w able 
to harvest and store donated valves 
for an indef in i te period through 
cryopreservatlon, a technique i n 
w h i c h tissue is frozen so that i ts 
l i v i n g cells are kept alive i n a state 
of suspended a n i m a t i o n . D o n a t e d 
valves are frozen i n l i q u i d n i t rogen 
u n t i l recprients are ident i f i ed for 
their use. T h e n the valves are 
thawed i n the operating r o o m and 
surgically i m p l a n t e d i n t o patients . 
" T h i s has become one of the most 
i m p o r t a n t advances i n valve 
surgery over the past decade," 
Shemin concludes. 
• FOR YOUR INFORMATION 
Dr. Shemin 
is chief of 
the Depart-
ment of 
Cardio-
thoracic 
Surgery and 
is a professor 
and chairper-
son of the Department of 
Cardiothoracic Surgery at Boston 
University School of Medicine. 
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P R O G R E S S F O L L O W - U P 
New drug and 
nniqne delivery 
control crippling 
mnscle spasms 
Imagine 
f i g h t i n g a 
l i fe long batt le 
against a 
debi l i ta t ing 
condi t ion , a 
c o n d i t i o n that , 
among other 
things, causes 
muscle spasms so p o w e r f u l and 
uncontrol lable that they prevent 
y o u f r o m eating or sleeping. 
According to an ongoing 
c l in ica l t r i a l being conducted at 
Boston U n i v e r s i t y Medica l 
Center/The U n i v e r s i t y Hospi ta l 
( B U M C H ) , m a n y patients w h o 
suffer f r o m such spasms because 
of a number of u n d e r l y i n g neuro-
logical condit ions could have their 
qual i ty of l i fe i m p r o v e d by a 
relat ively new drug administered 
i n a new way. 
The treatment is a drug called 
baclofen, a muscle-relaxing drug 
recently approved by the Federal 
Food and D m g A d m i n i s t r a t i o n 
(FDA) that has a lasting effect i n 
c o n t r o l l i n g muscle spasms. 
B U M C H , along w i t h Rush-
Presbyterian Medica l Center i n 
Chicago, has led the m u l t i c e n t e r 
study of baclofen, l o o k i n g specifi-
cally at the benefits derived f r o m 
its un ique del ivery t h r o u g h a 
computerized d m g p u m p . The 
patients part ic ipat ing i n the t r i a l 
are those whose spasms result 
f r o m either a spinal-cord i n j u r y or 
m u l t i p l e sclerosis. 
T h u s far, according to Joe I . 
Ordia , M . D . , a Hospi ta l 
neurosurgeon and the p r i m a r y 
invest igator of the baclofen study, 
59 pat ients w i t h these t w o 
condi t ions have been treated w i t h 
great success by h i m and his co-
investigators, Fdward Fischer, M . D . , 
a B U M C H neurologist, and Fdward 
L. Spatz, M . D . , B U M C H surgeon-in-
chief and chief of neurosurgery. " W e 
have seen patients experience a 
complete t u r n a r o u n d i n their a b i l i t y 
to f u n c t i o n f o l l o w i n g therapy," says 
Ordia . " T h e therapy provides 
i m m e d i a t e relief of spasms and 
offers a tremendous i m p r o v e m e n t i n 
the qua l i ty of l i fe for these pat ients . " 
A powerful drug 
His tor i ca l ly , the o n l y m e t h o d for 
treat ing uncontrol lable muscle 
spasms that d i d not respond to oral 
muscle relaxants was surgery, w h i c h 
permanent ly destroyed the nerve 
causing the spasms, or chemical 
injections, w h i c h t y p i c a l l y lost their 
effectiveness over t i m e . 
Baclofen or ig ina l ly was i n t r o -
duced i n the mid-1970s as an oral 
medica t ion that showed promise for 
c o n t r o l l i n g muscle spasms, but the 
drug had l i m i t a t i o n s . " O r a l baclofen 
was effective i n o n l y 35 percent of 
patients because m u c h of the d m g 
was absorbed i n t o the stomach, the 
bloodstream and even the b r a i n , " 
explains Ordia. " A s a result , large 
doses were needed i n order for the 
d m g to be effect ive." 
Researchers t h e n set out to 
develop a l i q u i d f o r m of baclofen 
that could be delivered direct ly to 
the nerve that was causing the 
spasm. "Baclofen is m u c h more 
effective w h e n i t is delivered direct ly 
to the spinal cord, the source of 
spasms," adds Ordia. " A n d because 
i t can be given i n m u c h smaller 
doses t h a n oral baclofen, the side 
effects are avoided." 
A unique device enhances treatment 
Ordia and his colleagues at B U M C H 
helped i n the development of the 
system used for adminis ter ing the 
dmg, a p u m p that delivers specific 
doses of l i q u i d baclofen direct ly to 
the spinal cord. They d id so using 
technology provided by Medtronic , 
Inc., a Minneapolis-based f i r m . 
Three years and dozens of patients 
later, the SynchroMed In fus ion 
System and baclofen appear to be a 
perfect match , and the answer for 
patients seeking relief f r o m their 
spasms. 
The p u m p , about the size of a 
hockey puck, is i m p l a n t e d hy a 
neurosurgeon i n t o the s k i n 
beneath the abdomen. Once i m -
planted, i t is programmed t h r o u g h 
a l i n k - u p to a desktop computer to 
dispense a specific a m o u n t of 
baclofen at specific t i m e intervals . 
" A major advantage of th is device 
is that i t doesn't require any 
compliance by the p a t i e n t — i t is 
preprogrammed," says Ordia. " A l l 
the pat ient has to do is make sure 
he or she comes i n for 30 m i n u t e s 
every t w o or three m o n t h s to r e f i l l 
the p u m p . " 
D m g pumps have endless 
possibil it ies. Other types of 
pumps are already being used at 
B U M C H and elsewhere to deliver 
m o r p h i n e to patients w i t h intrac-
table pain and to give chemo-
therapy to cancer patients. 
Michael R. Paskavitz 
FOR YOUR INFORMATION 
Dr. Ordia is 
a member 
of the 
Department 
of Neuro-
surgery and 
is an 
associate 
professor of 
neurosurgery at Boston Univer-
sity School of Medicine. 
For more information on the 
homograft procedure or the 
baclofen pump, or on other 
cardiothoracic surgery or 
neurosurgical procedures offered 
at the Hospital, please call 1-800-
842-3648 during business hours. 
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O n M a r c h 1, the Hospi ta l opened the 
doors to a major new heal th care 
center at 930 C o m m o n w e a l t h A v e . 
for Boston U n i v e r s i t y faculty , staff, 
the ir famil ies and Boston-area 
residents. Cal led the Common-
wealth Medical Group ( C M C ) , the 
mul t i spec ia l ty group practice 
provides a comprehensive range of 
outpat ient adult and pediatric 
p r i m a r y care services, as w e l l as a 
number of specialties, i n c l u d i n g 
obstetrics and gynecology, ophthal -
mology, dermatology, orthopedics, 
otolaryngology (ENT), pulmonary/ 
allergy and m e n t a l heal th . 
John H . Valentine Jr. was elected as 
the new chairperson of the 
Hospital 's Board of Tmstees at the 
138th A n n u a l M e e t i n g of the 
Hospi ta l Corporat ion i n December. 
He succeeds Hugh Shepley, w h o 
he ld the pos i t ion for the past three 
years. Valent ine, a 12-year member 
John H. Valentine Ir., left, and Hugh Shepley 
of the board, is director of entrepre-
neur ia l management at Boston 
U n i v e r s i t y ' s H e a l t h Policy Ins t i tute 
and is the former president and 
proprietor of Beech H i l l Hospi ta l i n 
D u b l i n , N . H . 
Also i n December, the Hospi ta l 
Corporat ion elected new trustee 
Robert P. Hanafee Jr., president of 
the stationery products d i v i s i o n at 
the G i l l e t t e Company, and three 
n e w overseers ( formerly called 
corporators): Cheryl L . Clarkson, 
acting chief executive officer of Peer 
Review Analysis , Inc.; T u a n Ha-
Ngoc, executive vice president of the 
Genetics Ins t i tute , and Chauncey C . 
Mayfield, deputy director of eco-
n o m i c development for the Eco-
n o m i c Development &t Industr ia l 
Corporat ion of Boston. 
N 
U . S . Sen. Edward 
M . Kennedy 
chaired a U.S. 
Senate Labor and 
H u m a n Resources 
C o m m i t t e e f ie ld 
hearing on 
women ' s heal th 
Sen. Edw. M. Kennedy research at BoStOU 
U n i v e r s i t y M e d i c a l Center on 
Jan. 11, acknowledging a dire need to 
boost federal f u n d i n g for, and to 
promote research on, women's 
heal th . Speaking to some 400 
members of the Medica l Center 
c o m m u n i t y . N a t i o n a l Inst i tutes of 
H e a l t h (NIH) Direc tor Bernadine 
Healy, M . D . , provided an overview 
of the N I H ' s miss ion to bolster the 
lagging research i n this area. Her 
remarks were fo l lowed by the 
t e s t i m o n y of f ive other p r o m i n e n t 
female scientists, i n c l u d i n g t w o 
f r o m Boston U n i v e r s i t y School of 
Public H e a l t h . 
Mel B. Glenn, M . D . , is the 
Hospital 's new chief of rehabi l i ta t ion 
medicine, succeeding Murray M . 
Freed, M . D . , w h o served at the 
Hospi ta l for 37 years. G l e n n , w h o 
came to the Hospi ta l f r o m T u f t s 
U n i v e r s i t y School of Medic in e , also 
assumed the roles of chairperson of 
the rehabi l i ta t ion medic ine depart-
m e n t at Boston U n i v e r s i t y School of 
Medic ine and director of rehabi l i ta-
t i o n medicine at Boston C i t y 
Hospi ta l . He received his medica l 
degree f r o m N e w Y o r k U n i v e r s i t y 
School of Medic ine and completed 
his post-graduate t ra in ing at the 
N e w Y o r k Univers i ty M e d i c a l 
Center. 
The Hospi ta l has upgraded its 
magnetic resonance imaging (MRI) 
technology. One of the p r i m a r y 
benefits of this new technology is 
that i t cuts i n half the t i m e i t takes 
to scan a patient for the image 
needed ( from 30 m i n u t e s to 15 
minutes) . The enhancement has 
enabled the Hospi ta l to increase the 
number of M R I examinations i t 
performs daily and to extend its 
services to more types of patients, 
i n c l u d i n g those w i t h bone, jo in t and 
musculoskeletal injuries. 
Th is past fa l l , 
the H o s p i t a l 
announced the 
reassignments 
of three senior 
managers: 
Susan R. 
Cerrone as-
sumed the 
n e w l y created 
pos i t ion of vice president for hospi-
tal i n f o r m a t i o n 
services; Donald R. 
Giller became vice 
president for 
regional opera-
tions, and 
Elizabeth B. 
Stengel undertook 
the post of vice 
president for 
external affairs. 
Su.tan R. Cerrone 
Elizabeth B. Stengel 
From left. Chauncev C. Mavfield. Chervl L. 
Clarkson. Tuan Ha-Ngoc, and Robert P. 
Hanafee Jr. 
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M A K I N G HOSPITAL DONATIONS 
WORK FOR Y O U 
Dr. Leonard Jones (not a real person), 65, a long-time supporter of 
Boston University Medical Center/The University Hospital (BUMCH), 
holds certificates of deposit (CDs) valued at $10,000 that w i l l mature 
soon. Realizing that roll ing his investment into new CDs would cam 
h i m an annual interest of less than 4 percent, he decided to explore 
higher yielding alternatives. 
Dr. Jones knew about the Hospital's new Planned Giving Program 
but had never explored how a gift to B U M C H could also meet his long-
term financial needs. By opting for a charitable gift annuity, a plan that 
would benefit both himself and the Hospital, he received: 
• A retum of 7.3 percent, or $730 annually, of which $315 is 
tax free; 
• a charitable income tax deduction of $3,718.40, eamed the 
year he made the gift; 
• a rate of retum that is guaranteed for the rest of his life, 
<• and the satisfaction of knowing that his gift benefitted the 
Leonard Jones Cancer Research Fund, the program of his 
choice. 
If you would like further information on how a charitable gift 
annuity could work for you, please complete and return the coupon 
below to Boston University Medical Center/The University Hospi-
tal, Development Office, 88 East Newton Street, Boston, MA 02118 or 
call 617/638-8943. 
I am interested i n learning more about charitable gift annuities. Please 
send me personalized investment scenarios based on the following 
information, wi thout any obligation on my part. 
Name 
Street 
City State Zip 
Date of Birth: 
Boston U n i v e r s i t y M e d i c a l Center/ 
The U n i v e r s i t y Hospi ta l 
88 East N e w t o n Street 
Boston M A 02118-2383 
Address Correct ion Requested 
N o n p r o f i t Organizat ion 
U.S. POSTAGE 
P A I D 
Boston, M A 
P E R M I T N O . 3469 
Cancer Answers^ CM up the phone l i s 
Boston University Medical Center/The University Hospital has 
become the greater Boston area's source for free, confidential and 
expert cancer information; a telephone service that puts cancer 
information at a caller's fingertips. 
Cancer HelpLink, the only resource 
of its kind in the region, is specifi-
cally designed for people who are 
interested in learning more about 
cancer and the cancer services 
available at Boston University 
Medical Center Hospital. Staffed by 
registered oncology nurses. Cancer 
HelpLink can provide callers with a 
total of 10,000 computer screens of 
current data on 40 different kinds of 
cancer. The Cancer HelpLink nurse, 
in addition to answering questions 
on a one-on-one basis, can refer 
concerned callers to Hospital physi-
cians according to their specialty, 
and recommend the most appropriate health care resource. 
...The next time you have a question about cancer, don't forget 
to make the connection with BUMC Cancer HelpLink by calling: 
4 - 8 5 4 1 
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